Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models

[1]  P. Bonate,et al.  A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1. , 2010, Blood.

[2]  F. Hyder,et al.  Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  G. Germino,et al.  Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. , 2010, Journal of the American Society of Nephrology : JASN.

[4]  V. Torres,et al.  Autosomal dominant polycystic kidney disease: the last 3 years. , 2009, Kidney international.

[5]  F. Hildebrandt,et al.  NEK8 mutations affect ciliary and centrosomal localization and may cause nephronophthisis. , 2008, Journal of the American Society of Nephrology : JASN.

[6]  P. Wahl,et al.  Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease , 2007, Nephrology.

[7]  J. Shayman,et al.  A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease. , 2007, Molecular genetics and metabolism.

[8]  A. Futerman,et al.  The metabolism and function of sphingolipids and glycosphingolipids , 2007, Cellular and Molecular Life Sciences.

[9]  D. Corbeil,et al.  GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells , 2007, FEBS letters.

[10]  Seng H. Cheng,et al.  Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 Diabetes , 2007, Diabetes.

[11]  Laurie A. Smith,et al.  Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine , 2006, Nature.

[12]  Laurie A. Smith,et al.  Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease. , 2006, Journal of the American Society of Nephrology : JASN.

[13]  P. Wahl,et al.  Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  L. Antiga,et al.  Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. , 2005, Kidney international.

[15]  L. Quarmby,et al.  Cilia and the cell cycle? , 2005, The Journal of cell biology.

[16]  O. A. Cabello,et al.  Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways , 2005, Nature Genetics.

[17]  Y. Tao,et al.  Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. , 2004, Journal of the American Society of Nephrology : JASN.

[18]  James P Calvet,et al.  Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype* , 2004, Journal of Biological Chemistry.

[19]  K. Liao,et al.  Insulin-like growth factor-1 receptor signaling in 3T3-L1 adipocyte differentiation requires lipid rafts but not caveolae , 2004, Cell Death and Differentiation.

[20]  Vincent H Gattone,et al.  Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist , 2003, Nature Medicine.

[21]  R. Proia,et al.  Enhanced insulin sensitivity in mice lacking ganglioside GM3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Rudolf Jaenisch,et al.  Rapid generation of inducible mouse mutants. , 2003, Nucleic acids research.

[23]  P. Igarashi,et al.  Genetics and pathogenesis of polycystic kidney disease. , 2002, Journal of the American Society of Nephrology : JASN.

[24]  Y. Igarashi,et al.  Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance* , 2002, The Journal of Biological Chemistry.

[25]  K. Jankowski.  Microdetermination of phosphorus in organic materials from polymer industry by microwave-induced plasma atomic emission spectrometry after microwave digestion , 2001 .

[26]  A. Abe,et al.  Improved Inhibitors of Glucosylceramide Synthase* , 1999, The Journal of Biological Chemistry.

[27]  S. Spiegel,et al.  Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate , 1996, Nature.

[28]  S. Chatterjee,et al.  Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease. , 1996, Journal of lipid research.

[29]  A. Rebbaa,et al.  Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. , 1996, Glycobiology.

[30]  N. Radin,et al.  Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk/cpk) mouse. , 1994, Journal of lipid research.

[31]  A. Abe,et al.  Improved inhibitors of glucosylceramide synthase. , 1992, The Journal of biological chemistry.

[32]  N. Radin,et al.  Modulation of renal epithelial cell growth by glucosylceramide. Association with protein kinase C, sphingosine, and diacylglycerol. , 1991, The Journal of biological chemistry.

[33]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[34]  R. Schrier,et al.  Potential Pharmacological Interventions in Polycystic Kidney Disease , 2012, Drugs.

[35]  F. Hildebrandt,et al.  Nephronophthisis: disease mechanisms of a ciliopathy. , 2009, Journal of the American Society of Nephrology : JASN.

[36]  Laurie A. Smith,et al.  Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures. , 2008, American journal of physiology. Renal physiology.

[37]  E. Bieberich.  Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: Review and Hypothesis , 2004, Glycoconjugate Journal.

[38]  J. Calvet,et al.  A hereditary model of slowly progressive polycystic kidney disease in the mouse. , 1991, Journal of the American Society of Nephrology : JASN.